Imitators of exercise-induced bronchoconstriction

Allergy, Asthma and Clinical Immunology

Volumn 5, Issue 1, 2009, Pages

  Weiss, Pnina ^a   Rundell, Kenneth W ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MARYWOOD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78650260797     PISSN: 17101484     EISSN: 17101492     Source Type: Journal    
DOI: 10.1186/1710-1492-5-7     Document Type: Review

References (129)

1. Anderson SD, Silverman M, Walker SR. Metabolic and ventilatory changes in asthmatic patients during and after exercise. Thorax 1972, 27:718-25. 10.1136/thx.27.6.718, 469970, 4647631.
2. Anderson SD, McEvoy JD, Bianco S. Changes in lung volumes and airway resistance after exercise in asthmatic subjects. Am Rev Respir Dis 1972, 106:30-7.
3. Godfrey S, Anderson SD, Silverman M. Physiologic aspects of exercise-induced asthma. Chest 1973, 63(Suppl):36S-7S. 10.1378/chest.63.4_Supplement.36S, 4695742.
4. McFadden ER, Nelson JA, Skowronski ME, Lenner KA. Thermally induced asthma and airway drying. Am J Respir Crit Care Med 1999, 160:221-6.
5. Busquets RM, Anto JM, Sunyer J, Sancho N, Vall O. Prevalence of asthma-related symptoms and bronchial responsiveness to exercise in children aged 13-14 yrs in Barcelona, Spain. Eur Respir J 1996, 9:2094-8. 10.1183/09031936.96.09102094, 8902472.
6. Seear M, Wensley D, West N. How accurate is the diagnosis of exercise induced asthma among Vancouver schoolchildren?. Arch Dis Child 2005, 90:898-902. 10.1136/adc.2004.063974, 1720580, 15855180.
7. McFadden ER, Gilbert IA. Exercise-induced asthma. N Engl J Med 1994, 330:1362-7. 10.1056/NEJM199405123301907, 8152449.
8. Sidiropoulou M, Tsimaras V, Fotiadou E, Aggelopoulou-Sakadami N. [Exercised-induced asthma in soccer players ages from 8 to 13 years]. Pneumologie 2005, 59:238-43. 10.1055/s-2004-830211, 15944897.
9. Cabral AL, Conceicao GM, Fonseca-Guedes CH, Martins MA. Exercise-induced bronchospasm in children: effects of asthma severity. Am J Respir Crit Care Med 1999, 159:1819-23.
10. Schoene RB, Giboney K, Schimmel C, Hagen J, Robinson J, Schoene RB, et al. Spirometry and airway reactivity in elite track and field athletes. Clin J Sport Med 1997, 7:257-61. 10.1097/00042752-199710000-00003, 9397324.
11. Feinstein RA, LaRussa J, Wang-Dohlman A, Bartolucci AA. Screening adolescent athletes for exercise-induced asthma. Clin J Sport Med 1996, 6:119-23.
12. Helenius IJ, Tikkanen HO, Haahtela T. Occurrence of exercise induced bronchospasm in elite runners: dependence on atopy and exposure to cold air and pollen. Br J Sports Med 1998, 32:125-9. 10.1136/bjsm.32.2.125, 1756081, 9631218.
13. Wilber RL, Rundell KW, Szmedra L, Jenkinson DM, Im J, Drake SD. Incidence of exercise-induced bronchospasm in Olympic winter sport athletes. Med Sci Sports Exerc 2000, 32:732-7. 10.1097/00005768-200004000-00003, 10776890.
14. Heir T, Oseid S. Self-reported asthma and exercise-induced asthma symptoms in high-level competitive cross-country skiers. Scand J Med Sci Sports 1994, 4:128-33.
15. Helenius IJ, Tikkanan HO, Haahtela T. Exercise-induced bronchospasm at low temperature in elite runners. Thorax 1996, 51:628-9. 10.1136/thx.51.6.628, 1090496, 8693447.
16. Rundell KW, Spiering BA, Evans TM, Baumann JM. Baseline lung function, exercise-induced bronchoconstriction, and asthma-like symptoms in elite women ice hockey players. Med Sci Sports Exerc 2004, 36:405-10. 10.1249/01.MSS.0000117118.77267.BF, 15076781.
17. Mannix ET, Manfredi F, Farber MO. A comparison of two challenge tests for identifying exercise-induced bronchospasm in figure skaters. Chest 1999, 115:649-53. 10.1378/chest.115.3.649, 10084470.
18. Mannix ET, Farber MO, Palange P, Galassetti P, Manfredi F. Exercise-induced asthma in figure skaters. Chest 1996, 109:312-5. 10.1378/chest.109.2.312, 8620698.
19. Provost-Craig MA, Arbour KS, Sestili DC, Chabalko JJ, Ekinci E. The incidence of exercise-induced bronchospasm in competitive figure skaters. J Asthma 1996, 33:67-71. 10.3109/02770909609077764, 8621373.
20. Holzer K, Anderson SD, Douglass J. Exercise in elite summer athletes: Challenges for diagnosis. J Allergy Clin Immunol 2002, 110:374-80. 10.1067/mai.2002.127784, 12209082.
21. Weiler JM, Layton T, Hunt M. Asthma in United States Olympic athletes who participated in the 1996 Summer Games. J Allergy Clin Immunol 1998, 102:722-6. 10.1016/S0091-6749(98)70010-7, 9819287.
22. Weiler JM, Metzger WJ, Donnelly AL, Crowley ET, Sharath MD. Prevalence of bronchial hyperresponsiveness in highly trained athletes. Chest 1986, 90:23-8. 10.1378/chest.90.1.23, 3522119.
23. Parsons JP, Kaeding C, Phillips G, Jarjoura D, Wadley G, Mastronarde JG. Prevalence of exercise-induced bronchospasm in a cohort of varsity college athletes. Med Sci Sports Exerc 2007, 39:1487-92. 10.1249/mss.0b013e3180986e45, 17805078.
24. Rundell KW, Im J, Mayers LB, Wilber RL, Szmedra L, Schmitz HR. Self-reported symptoms and exercise-induced asthma in the elite athlete. Med Sci Sports Exerc 2001, 33:208-13.
25. Rundell KW, Spiering BA, Baumann JM, Evans TM. Effects of montelukast on airway narrowing from eucapnic voluntary hyperventilation and cold air exercise. Br J Sports Med 2005, 39:232-6. 10.1136/bjsm.2004.014282, 1725192, 15793094.
26. Hofstra WB, Neijens HJ, Duiverman EJ, Kouwenberg JM, Mulder PG, Kuethe MC, et al. Dose-responses over time to inhaled fluticasone propionate treatment of exercise- and methacholine-induced bronchoconstriction in children with asthma. Pediatr Pulmonol 2000, 29:415-23. 10.1002/(SICI)1099-0496(200006)29:6<415::AID-PPUL1>3.0.CO;2-7, 10821721.
27. Anderson SD, Sue-Chu M, Perry CP, Gratziou C, Kippelen P, McKenzie DC, et al. Bronchial challenges in athletes applying to inhale a [beta]2-agonist at the 2004 Summer Olympics. Journal of Allergy and Clinical Immunology 2006, 117:767-73. 10.1016/j.jaci.2005.12.1355, 16630932.
28. Fitch KD, Sue-Chu M, Anderson SD, Boulet LP, Hancox RJ, McKenzie DC, et al. Asthma and the elite athlete: summary of the International Olympic Committee's consensus conference, Lausanne, Switzerland, January 22-24, 2008. J Allergy Clin Immunol 2008, 122:254-60. 60 e1-7, 10.1016/j.jaci.2008.07.003, 18678340.
29. Rundell KW, Jenkinson DM. Exercise-induced bronchospasm in the elite athlete. Sports Med 2002, 32:583-600. 10.2165/00007256-200232090-00004, 12096931.
30. Weinberger M, Abu-Hasan M. Perceptions and pathophysiology of dyspnea and exercise intolerance. Pediatr Clin North Am 2009, 56:33-48. 10.1016/j.pcl.2008.10.015, 19135580.
31. Weinberger M. Exercise induced dyspnoea: if not asthma, then what?. Arch Dis Child 2006, 91:543-4. 10.1136/adc.2006.095000, 2082800, 16714739.
32. Joyner BL, Fiorino EK, Matta-Arroyo E, Needleman JP. Cardiopulmonary exercise testing in children and adolescents with asthma who report symptoms of exercise-induced bronchoconstriction. J Asthma 2006, 43:675-8. 10.1080/02770900600925460, 17092848.
33. De Baets F, Bodart E, Dramaix-Wilmet M, Van Daele S, de Bilderling G, Masset S, et al. Exercise-induced respiratory symptoms are poor predictors of bronchoconstriction. Pediatr Pulmonol 2005, 39:301-5. 10.1002/ppul.20185, 15678500.
34. Abu-Hasan M, Tannous B, Weinberger M. Exercise-induced dyspnea in children and adolescents: if not asthma then what?. Ann Allergy Asthma Immunol 2005, 94:366-71.
35. Hallstrand TS, Bates PW, Schoene RB. Aerobic conditioning in mild asthma decreases the hyperpnea of exercise and improves exercise and ventilatory capacity. Chest 2000, 118:1460-9. 10.1378/chest.118.5.1460, 11083702.
36. Matsumoto I, Araki H, Tsuda K, Odajima H, Nishima S, Higaki Y, et al. Effects of swimming training on aerobic capacity and exercise induced bronchoconstriction in children with bronchial asthma. Thorax 1999, 54:196-201. 1745437, 10325893.
37. Haas F, Pasierski S, Levine N, Bishop M, Axen K, Pineda H, et al. Effect of aerobic training on forced expiratory airflow in exercising asthmatic humans. J Appl Physiol 1987, 63:1230-5.
38. Gibson GJ. Obesity, respiratory function and breathlessness. Thorax 2000, 55:S41-4. 10.1136/thorax.55.suppl_1.S41, 1765949, 10943638.
39. Sin DD, Jones RL, Man SFP. Obesity Is a Risk Factor for Dyspnea but Not for Airflow Obstruction. Arch Intern Med 2002, 162:1477-81. 10.1001/archinte.162.13.1477, 12090884.
40. Babb TG, Ranasinghe KG, Comeau LA, Semon TL, Schwartz B. Dyspnea on Exertion in Obese Women: Association with an Increased Oxygen Cost of Breathing. Am J Respir Crit Care Med 2008, 178:116-23. 10.1164/rccm.200706-875OC, 18420968.
41. Parameswaran K, Todd DC, Soth M. Altered respiratory physiology in obesity. Can Respir J 2006, 13:203-10. 2683280, 16779465.
42. Koenig SM. Pulmonary complications of obesity. Am J Med Sci 2001, 321:249-79. 10.1097/00000441-200104000-00006, 11307867.
43. Bedell GN, Wilson WR, Seebohm PM. Pulmonary function in obese persons. J Clin Invest 1958, 37:1049-60. 10.1172/JCI103686, 1062767, 13563634.
44. Ray CS, Sue DY, Bray G, Hansen JE, Wasserman K. Effects of obesity on respiratory function. Am Rev Respir Dis 1983, 128:501-6.
45. Sharp JT, Henry JP, Sweany SK, Meadows WR, Pietras RJ. The Total Work of Breathing in Normal and Obese Men. J Clin Invest 1964, 43:728-39. 10.1172/JCI104957, 289549, 14149924.
46. Jensen D, Webb KA, Davies GA, O'Donnell DE. Mechanical ventilatory constraints during incremental cycle exercise in human pregnancy: Implications for respiratory sensation. J Physiol 2008, 586:4735-50. 10.1113/jphysiol.2008.158154, 2614045, 18687714.
47. Salvadori A, Fanari P, Fontana M, Buontempi L, Saezza A, Baudo S, et al. Oxygen uptake and cardiac performance in obese and normal subjects during exercise. Respiration 1999, 66:25-33. 10.1159/000029333, 9973687.
48. Salome CM, Munoz PA, Berend N, Thorpe CW, Schachter LM, King GG. Effect of obesity on breathlessness and airway responsiveness to methacholine in non-asthmatic subjects. Int J Obes (Lond) 2008, 32:502-9. 10.1038/sj.ijo.0803752, 17955030.
49. Thomson CC, Clark S, Camargo CA. Body Mass Index and Asthma Severity Among Adults Presenting to the Emergency Department. Chest 2003, 124:795-802. 10.1378/chest.124.3.795, 12970000.
50. Karason K, Lindroos AK, Stenlof K, Sjostrom L. Relief of Cardiorespiratory Symptoms and Increased Physical Activity After Surgically Induced Weight Loss: Results From the Swedish Obese Subjects Study. Arch Intern Med 2000, 160:1797-802. 10.1001/archinte.160.12.1797, 10871973.
51. McFadden ER, Zawadski DK. Vocal cord dysfunction masquerading as exercise-induced asthma. a physiologic cause for "choking" during athletic activities. Am J Respir Crit Care Med 1996, 153:942-7.
52. Morris CK, Myers J, Froelicher VF, Kawaguchi T, Ueshima K, Hideg A. Nomogram based on metabolic equivalents and age for assessing aerobic exercise capacity in men. J Am Coll Cardiol 1993, 22:175-82.
53. Rundell KW, Spiering BA. Inspiratory stridor in elite athletes. Chest 2003, 123:468-74. 10.1378/chest.123.2.468, 12576368.
54. Heatley DG, Swift E. Paradoxical vocal cord dysfunction in an infant with stridor and gastroesophageal reflux. Int J Pediatr Otorhinolaryngol 1996, 34:149-51. 10.1016/0165-5876(95)01230-3, 8770682.
55. Newman KB, Mason UG, Schmaling KB. Clinical features of vocal cord dysfunction. Am J Respir Crit Care Med 1995, 152:1382-6.
56. Christopher KL, Wood RP, Eckert RC, Blager FB, Raney RA, Souhrada JF. Vocal-cord dysfunction presenting as asthma. N Engl J Med 1983, 308:1566-70.
57. Newsham KR, Klaben BK, Miller VJ, Saunders JE. Paradoxical Vocal-Cord Dysfunction: Management in Athletes. J Athl Train 2002, 37:325-8. 164364, 12937590.
58. Blager FB, Gay ML, Wood RP. Voice therapy techniques adapted to treatment of habit cough: a pilot study. J Commun Disord 1988, 21:393-400. 10.1016/0021-9924(88)90024-X, 3183084.
59. Fahey JT, Bryant NJ, Karas D, Goldberg B, Destefano R, Gracco LC. Exercise-induced stridor due to abnormal movement of the arytenoid area: videoendoscopic diagnosis and characterization of the "at risk" group. Pediatr Pulmonol 2005, 39:51-5. 10.1002/ppul.20076, 15558600.
60. Mandell DL, Arjmand EM. Laryngomalacia induced by exercise in a pediatric patient. Int J Pediatr Otorhinolaryngol 2003, 67:999-1003. 10.1016/S0165-5876(03)00178-2, 12907057.
61. Smith RJ, Bauman NM, Bent JP, Kramer M, Smits WL, Ahrens RC. Exercise-induced laryngomalacia. Ann Otol Rhinol Laryngol 1995, 104:537-41.
62. Bent JP, Miller DA, Kim JW, Bauman NM, Wilson JS, Smith RJ. Pediatric exercise-induced laryngomalacia. Ann Otol Rhinol Laryngol 1996, 105:169-75.
63. Hammo AH, Weinberger MM. Exercise-induced hyperventilation: a pseudoasthma syndrome. Ann Allergy Asthma Immunol 1999, 82:574-8.
64. Morgan WP. Hyperventilation syndrome: a review. Am Ind Hyg Assoc J 1983, 44:685-9.
65. Bass C. Hyperventilation syndrome: a chimera?. J Psychosom Res 1997, 42:421-6. 10.1016/S0022-3999(96)00365-0, 9194014.
66. Salkovskis PM, Clark DM. Affective responses to hyperventilation: a test of the cognitive model of panic. Behav Res Ther 1990, 28:51-61. 10.1016/0005-7967(90)90054-M, 2302149.
67. Salkovskis PM, Jones DR, Clark DM. Respiratory control in the treatment of panic attacks: replication and extension with concurrent measurement of behaviour and pCO2. Br J Psychiatry 1986, 148:526-32. 10.1192/bjp.148.5.526, 3096411.
68. Rietveld S, Houtveen JH. Acquired sensitivity to relevant physiological activity in patients with chronic health problems. Behav Res Ther 2004, 42:137-53. 10.1016/S0005-7967(03)00104-9, 14975777.
69. Wientjes CJ, Grossman P. Overreactivity of the psyche or the soma? Interindividual associations between psychosomatic symptoms, anxiety, heart rate, and end-tidal partial carbon dioxide pressure. Psychosom Med 1994, 56:533-40.
70. Rietveld S, van Beest I. Rollercoaster asthma: when positive emotional stress interferes with dyspnea perception. Behav Res Ther 2007, 45:977-87. 10.1016/j.brat.2006.07.009, 16989773.
71. Rietveld S, Creer TL. Psychiatric factors in asthma: implications for diagnosis and therapy. Am J Respir Med 2003, 2:1-10.
72. Rietveld S, Brosschot JF. Current perspectives on symptom perception in asthma: a biomedical and psychological review. Int J Behav Med 1999, 6:120-34. 10.1207/s15327558ijbm0602_2, 16250683.
73. De Pascalis V, Chiaradia C, Carotenuto E. The contribution of suggestibility and expectation to placebo analgesia phenomenon in an experimental setting. Pain 2002, 96:393-402. 10.1016/S0304-3959(01)00485-7, 11973014.
74. Anbar RD. Self-hypnosis for management of chronic dyspnea in pediatric patients. Pediatrics 2001, 107:E21. 10.1542/peds.107.2.e21, 11158495.
75. Ross RM. ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 2003, 167:1451. author reply.
76. Reindl I, Kleber FX. Exertional hyperpnea in patients with chronic heart failure is a reversible cause of exercise intolerance. Basic Res Cardiol 1996, 91(Suppl 1):37-43.
77. D'Alonzo GE, Gianotti LA, Pohil RL, Reagle RR, DuRee SL, Fuentes F, et al. Comparison of progressive exercise performance of normal subjects and patients with primary pulmonary hypertension. Chest 1987, 92:57-62. 10.1378/chest.92.1.57, 3109813.
78. Rastogi D, Ngai P, Barst RJ, Koumbourlis AC. Lower airway obstruction, bronchial hyperresponsiveness, and primary pulmonary hypertension in children. Pediatr Pulmonol 2004, 37:50-5. 10.1002/ppul.10363, 14679489.
79. Meyer FJ, Ewert R, Hoeper MM, Olschewski H, Behr J, Winkler J, et al. Peripheral airway obstruction in primary pulmonary hypertension. Thorax 2002, 57:473-6. 10.1136/thorax.57.6.473, 1746348, 12037220.
80. Achouh L, Montani D, Garcia G, Jais X, Hamid AM, Mercier O, et al. Pulmonary arterial hypertension masquerading as severe refractory asthma. Eur Respir J 2008, 32:513-6. 10.1183/09031936.00005408, 18669791.
81. Efthimiadis GK, Giannakoulas G, Parcharidou DG, Ziakas AG, Papadopoulos CE, Karoulas T, et al. Subaortic and midventricular obstructive hypertrophic cardiomyopathy with extreme segmental hypertrophy. 2007, 5:12. Cardiovasc Ultrasound, 1829155, 17349063.
82. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. Jama 2002, 287:1308-20. 10.1001/jama.287.10.1308, 11886323.
83. Frank MJ, Abdulla AM, Watkins LO, Prisant L, Stefadouros MA. Long-term medical management of hypertrophic cardiomyopathy: usefulness of propranolol. Eur Heart J 1983, 4(Suppl F):155-64.
84. Nishimura RA, Holmes DR. Hypertrophic Obstructive Cardiomyopathy. N Engl J Med 2004, 350:1320-7. 10.1056/NEJMcp030779, 15044643.
85. Pelliccia A, Maron BJ, Di Paolo FM, Biffi A, Quattrini FM, Pisicchio C, et al. Prevalence and clinical significance of left atrial remodeling in competitive athletes. J Am Coll Cardiol 2005, 46:690-6. 10.1016/j.jacc.2005.04.052, 16098437.
86. Chatillon J. [Dyspnea on exercise, early symptom of Mobitz type II atrio-ventricular block (author's transl)]. Schweiz Rundsch Med Prax 1978, 67:185-90.
87. Besley DC, McWilliams GJ, Moodie DS, Castle LW. Long-term follow-up of young adults following permanent pacemaker placement for complete heart block. Am Heart J 1982, 103:332-7. 10.1016/0002-8703(82)90270-8, 6801942.
88. Schofield PM, Bowes RJ, Brooks N, Bennett DH. Exercise capacity and spontaneous heart rhythm after transvenous fulguration of atrioventricular conduction. Br Heart J 1986, 56:358-65. 10.1136/hrt.56.4.358, 1236871, 3768215.
89. Lelovas P, Dontas I, Bassiakou E, Xanthos T. Cardiac implications of Lyme disease, diagnosis and therapeutic approach. Int J Cardiol 2008, 129:15-21. 10.1016/j.ijcard.2008.01.044, 18508142.
90. Parker JM, Cary-Freitas B, Berg BW. Symptomatic vascular rings in adulthood: an uncommon mimic of asthma. J Asthma 2000, 37:275-80. 10.3109/02770900009055450, 10831152.
91. Grathwohl KW, Afifi AY, Dillard TA, Olson JP, Heric BR. Vascular rings of the thoracic aorta in adults. Am Surg 1999, 65:1077-83.
92. Gossage JR, Kanj G. Pulmonary arteriovenous malformations. A state of the art review. Am J Respir Crit Care Med 1998, 158:643-61.
93. Shovlin CL, Letarte M. Rare diseases bullet 4: Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms. Thorax 1999, 54:714-29. 1745557, 10413726.
94. Haitjema T, Disch F, Overtoom TT, Westermann CJ, Lammers JW. Screening family members of patients with hereditary hemorrhagic telangiectasia. Am J Med 1995, 99:519-24. 10.1016/S0002-9343(99)80229-0, 7485210.
95. Shovlin CL, Jackson JE, Bamford KB, Jenkins IH, Benjamin AR, Ramadan H, et al. Primary determinants of ischaemic stroke/brain abscess risks are independent of severity of pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia. Thorax 2008, 63:259-66. 10.1136/thx.2007.087452, 17981912.
96. Robin ED, Laman D, Horn BR, Theodore J. Platypnea related to orthodeoxia caused by true vascular lung shunts. N Engl J Med 1976, 294:941-3.
97. Dutton JA, Jackson JE, Hughes JM, Whyte MK, Peters AM, Ussov W, et al. Pulmonary arteriovenous malformations: results of treatment with coil embolization in 53 patients. AJR Am J Roentgenol 1995, 165:1119-25.
98. Terry PB, White RI, Barth KH, Kaufman SL, Mitchell SE. Pulmonary arteriovenous malformations. Physiologic observations and results of therapeutic balloon embolization. N Engl J Med 1983, 308:1197-200.
99. Pennington DW, Gold WM, Gordon RL, Steiger D, Ring EJ, Golden JA. Treatment of pulmonary arteriovenous malformations by therapeutic embolization. Rest and exercise physiology in eight patients. Am Rev Respir Dis 1992, 145:1047-51.
100. Gupta P, Mordin C, Curtis J, Hughes JM, Shovlin CL, Jackson JE. Pulmonary arteriovenous malformations: effect of embolization on right-to-left shunt, hypoxemia, and exercise tolerance in 66 patients. AJR Am J Roentgenol 2002, 179:347-55.
101. Remy J, Remy-Jardin M, Giraud F, Wattinne L. Angioarchitecture of pulmonary arteriovenous malformations: clinical utility of three-dimensional helical CT. Radiology 1994, 191:657-64.
102. Remy J, Remy-Jardin M, Wattinne L, Deffontaines C. Pulmonary arteriovenous malformations: evaluation with CT of the chest before and after treatment. Radiology 1992, 182:809-16.
103. Thompson RD, Jackson J, Peters AM, Dore CJ, Hughes JM. Sensitivity and specificity of radioisotope right-left shunt measurements and pulse oximetry for the early detection of pulmonary arteriovenous malformations. Chest 1999, 115:109-13. 10.1378/chest.115.1.109, 9925070.
104. Dickinson JW, Whyte GP, McConnell AK, Nevill AM, Harries MG. Mid-expiratory flow versus FEV1 measurements in the diagnosis of exercise induced asthma in elite athletes. Thorax 2006, 61:111-4. 10.1136/thx.2005.046615, 2104577, 16227323.
105. Cottin V, Plauchu H, Bayle J-Y, Barthelet M, Revel D, Cordier J-F. Pulmonary Arteriovenous Malformations in Patients with Hereditary Hemorrhagic Telangiectasia. Am J Respir Crit Care Med 2004, 169:994-1000. 10.1164/rccm.200310-1441OC, 14742303.
106. Chuang ML, Chang HC, Lim KE, Vintch JR. Gas exchange detection of right-to-left shunt in dyspneic patients: report of three cases. Int J Cardiol 2006, 108:117-9. 10.1016/j.ijcard.2005.02.022, 16516706.
107. Schneider G, Uder M, Koehler M, Kirchin MA, Massmann A, Buecker A, et al. MR Angiography for Detection of Pulmonary Arteriovenous Malformations in Patients with Hereditary Hemorrhagic Telangiectasia. Am J Roentgenol 2008, 190:892-901.
108. Zukotynski K, Chan RP, Chow C-M, Cohen JH, Faughnan ME. Contrast Echocardiography Grading Predicts Pulmonary Arteriovenous Malformations on CT. Chest 2007, 132:18-23. 10.1378/chest.06-2356, 17317734.
109. Fonkalsrud EW, Dunn JC, Atkinson JB. Repair of pectus excavatum deformities: 30 years of experience with 375 patients. Ann Surg 2000, 231:443-8. 10.1097/00000658-200003000-00019, 1421017, 10714639.
110. Jaroszewski DE, Fonkalsrud EW. Repair of pectus chest deformities in 320 adult patients: 21 year experience. Ann Thorac Surg 2007, 84:429-33. 10.1016/j.athoracsur.2007.03.077, 17643611.
111. Fonkalsrud EW, DeUgarte D, Choi E. Repair of pectus excavatum and carinatum deformities in 116 adults. Ann Surg 2002, 236:304-12. 10.1097/00000658-200209000-00007, 1422584, 12192317.
112. Smyth RJ, Chapman KR, Wright TA, Crawford JS, Rebuck AS. Ventilatory patterns during hypoxia, hypercapnia, and exercise in adolescents with mild scoliosis. Pediatrics 1986, 77:692-7.
113. Garfinkel SK, Kesten S, Chapman KR, Rebuck AS. Physiologic and nonphysiologic determinants of aerobic fitness in mild to moderate asthma. Am Rev Respir Dis 1992, 145:741-5.
114. Finder JD. Primary bronchomalacia in infants and children. J Pediatr 1997, 130:59-66. 10.1016/S0022-3476(97)70311-1, 9003852.
115. Boogaard R, Huijsmans SH, Pijnenburg MW, Tiddens HA, de Jongste JC, Merkus PJ. Tracheomalacia and bronchomalacia in children: incidence and patient characteristics. Chest 2005, 128:3391-7. 10.1378/chest.128.5.3391, 16304290.
116. Marciniuk DD, Sridhar G, Clemens RE, Zintel TA, Gallagher CG. Lung volumes and expiratory flow limitation during exercise in interstitial lung disease. J Appl Physiol 1994, 77:963-73.
117. Harris-Eze AO, Sridhar G, Clemens RE, Zintel TA, Gallagher CG, Marciniuk DD. Role of hypoxemia and pulmonary mechanics in exercise limitation in interstitial lung disease. Am J Respir Crit Care Med 1996, 154:994-1001.
118. O'Donnell DE, Chau LK, Webb KA. Qualitative aspects of exertional dyspnea in patients with interstitial lung disease. J Appl Physiol 1998, 84:2000-9.
119. Ofir D, Laveneziana P, Webb KA, Lam YM, O'Donnell DE. Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008, 177:622-9. 10.1164/rccm.200707-1064OC, 18006885.
120. O'Donnell DE, Banzett RB, Carrieri-Kohlman V, Casaburi R, Davenport PW, Gandevia SC, et al. Pathophysiology of dyspnea in chronic obstructive pulmonary disease: a roundtable. Proc Am Thorac Soc 2007, 4:145-68. 10.1513/pats.200611-159CC, 17494725.
121. Nery LE, Wasserman K, Andrews JD, Huntsman DJ, Hansen JE, Whipp BJ. Ventilatory and gas exchange kinetics during exercise in chronic airways obstruction. J Appl Physiol 1982, 53:1594-602.
122. Carter R, Nicotra B, Blevins W, Holiday D. Altered exercise gas exchange and cardiac function in patients with mild chronic obstructive pulmonary disease. Chest 1993, 103:745-50. 10.1378/chest.103.3.745, 8449062.
123. van Adel BA, Tarnopolsky MA. Metabolic myopathies: update 2009. J Clin Neuromuscul Dis 2009, 10:97-121. 10.1097/CND.0b013e3181903126, 19258857.
124. Hooper RG, Thomas AR, Kearl RA. Mitochondrial enzyme deficiency causing exercise limitation in normal-appearing adults. Chest 1995, 107:317-22. 10.1378/chest.107.2.317, 7842754.
125. Haller RG, Lewis SF, Estabrook RW, DiMauro S, Servidei S, Foster DW. Exercise intolerance, lactic acidosis, and abnormal cardiopulmonary regulation in exercise associated with adult skeletal muscle cytochrome c oxidase deficiency. J Clin Invest 1989, 84:155-61. 10.1172/JCI114135, 303965, 2544623.
126. Flaherty KR, Wald J, Weisman IM, Zeballos RJ, Schork MA, Blaivas M, et al. Unexplained exertional limitation: characterization of patients with a mitochondrial myopathy. Am J Respir Crit Care Med 2001, 164:425-32.
127. Rundell KW, Slee JB. Exercise and other indirect challenges to demonstrate asthma or exercise-induced bronchoconstriction in athletes. J Allergy Clin Immunol 2008, 122:238-46. 10.1016/j.jaci.2008.06.014, 18678339.
128. Karjalainen EM, Laitinen A, Sue-Chu M, Altraja A, Bjermer L, Laitinen LA. Evidence of airway inflammation and remodeling in ski athletes with and without bronchial hyperresponsiveness to methacholine. Am J Respir Crit Care Med 2000, 161:2086-91.
129. Henriksen AH, Tveit KH, Holmen TL, Sue-Chu M, Bjermer L. A study of the association between exercise-induced wheeze and exercise versus methacholine-induced bronchoconstriction in adolescents. Pediatr Allergy Immunol 2002, 13:203-8. 10.1034/j.1399-3038.2002.01034.x, 12144643.